Kuros Biosciences Overview
- Year Founded
-
2000
- Status
-
Public
- Employees
-
213
- Stock Symbol
-
KURN
- Investments
-
2
- Share Price
-
$23.29
- (As of Friday Closing)
Kuros Biosciences General Information
Description
Kuros Biosciences Ltd is a Swiss-based biotech company, focused on developing and commercializing biologic bone graft technologies for musculoskeletal applications, particularly in spine, trauma, extremities, and oncology. It has two reportable segments: i) Medical Devices: This segment includes products such as MagnetOs and Attrax, which are biphasic calcium phosphate (BCP) bone grafts that mimic the porous, trabecular structure of cancellous bone. ii) Legacy Portfolio: This segment includes all non-core products (including Checkmate licensing) that are outside the Group's primary therapeutic focus. The majority of the company's revenue is derived from the Medical Devices segment. Geographically, it generates the maximum revenue from the United States of America.
Contact Information
Website
www.kurosbio.comCorporate Office
- Wagistrasse 25
- Schlieren
- 8952 Zurich
- Switzerland
Corporate Office
- Wagistrasse 25
- Schlieren
- 8952 Zurich
- Switzerland
Kuros Biosciences Stock Performance
As of 13-Nov-2026, Kuros Biosciences’s stock price is $23.29. Its current market cap is $926M with 39.8M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $23.29 | $23.67 | $19.95 - $40.36 | $926M | 39.8M | 224K | $0.23 |
Kuros Biosciences Financials Summary
As of 30-Jun-2026, Kuros Biosciences has a trailing 12-month revenue of $175M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 924,928 | 1,339,671 | 875,715 | 135,019 |
| Revenue | 174,932 | 146,058 | 85,159 | 37,338 |
| EBITDA | 9,118 | 8,652 | (817) | (8,052) |
| Net Income | 8,969 | 2,551 | (4,835) | (11,298) |
| Total Assets | 148,944 | 133,875 | 92,702 | 85,082 |
| Total Debt | 10,067 | 1,390 | 1,966 | 2,551 |
Kuros Biosciences Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Kuros Biosciences Patents
Kuros Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2022217100-A1 | Porous osteoinductive composites | Active | 02-Feb-2021 | ||
| AU-2022217100-B2 | Porous osteoinductive composites | Active | 02-Feb-2021 | ||
| EP-4288122-A1 | Porous osteoinductive composites | Pending | 02-Feb-2021 | ||
| JP-2025130730-A | Porous osteoinductive composites | Pending | 02-Feb-2021 | ||
| US-20240131226-A1 | Porous osteoinductive composites | Pending | 02-Feb-2021 | A61L27/46 |
Kuros Biosciences Signals
Kuros Biosciences Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Kuros Biosciences Acquisitions (2)
Kuros Biosciences’s most recent deal was a Merger/Acquisition with Xpand Biotechnology for . The deal was made on 23-Jan-2017.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Xpand Biotechnology | 23-Jan-2017 | Merger/Acquisition | Discovery Tools (Healthcare) | ||
| Cytos Biotechnology | 18-Jan-2016 | Merger/Acquisition | Drug Discovery |
Kuros Biosciences ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Devices
Subindustry
Rank
Percentile
Kuros Biosciences FAQs
-
When was Kuros Biosciences founded?
Kuros Biosciences was founded in 2000.
-
Where is Kuros Biosciences headquartered?
Kuros Biosciences is headquartered in Zurich, Switzerland.
-
What is the size of Kuros Biosciences?
Kuros Biosciences has 213 total employees.
-
What industry is Kuros Biosciences in?
Kuros Biosciences’s primary industry is Surgical Devices.
-
Is Kuros Biosciences a private or public company?
Kuros Biosciences is a Public company.
-
What is Kuros Biosciences’s stock symbol?
The ticker symbol for Kuros Biosciences is KURN.
-
What is the current stock price of Kuros Biosciences?
As of 13-Nov-2026 the stock price of Kuros Biosciences is $23.29.
-
What is the current market cap of Kuros Biosciences?
The current market capitalization of Kuros Biosciences is $926M.
-
What is Kuros Biosciences’s current revenue?
The trailing twelve month revenue for Kuros Biosciences is $175M.
-
What is Kuros Biosciences’s annual earnings per share (EPS)?
Kuros Biosciences’s EPS for 12 months was $0.23.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process